tiprankstipranks
Trending News
More News >
Neuroscientific Biopharmaceuticals Ltd. (AU:NSB)
ASX:NSB
Australian Market
Advertisement

Neuroscientific Biopharmaceuticals Ltd. (NSB) Ratios

Compare
6 Followers

Neuroscientific Biopharmaceuticals Ltd. Ratios

AU:NSB's free cash flow for Q4 2025 was AU$0.00. For the 2025 fiscal year, AU:NSB's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
179.30 58.87 8.39 3.34 64.58
Quick Ratio
179.30 58.87 8.39 3.34 64.58
Cash Ratio
172.79 57.82 8.22 3.25 63.39
Solvency Ratio
49.26 4.85 -1.69 -4.68 -13.95
Operating Cash Flow Ratio
44.49 0.52 -3.86 -3.13 -11.64
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 7.25MAU$ 4.96MAU$ 4.41MAU$ 5.18MAU$ 14.20M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.01 1.02 1.13 1.40 1.02
Debt Service Coverage Ratio
0.00 0.00 -213.51 0.00 -49.47K
Interest Coverage Ratio
0.00 0.00 -1.29K 0.00 -67.04K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 <0.01 0.00 <0.01
Net Debt to EBITDA
3.79 2.76 0.82 0.70 4.54
Profitability Margins
Gross Profit Margin
0.00%-4.13%98.83%0.00%93.60%
EBIT Margin
0.00%-85.36%-121.58%0.00%-331.45%
EBITDA Margin
0.00%-81.20%-120.41%0.00%-325.04%
Operating Profit Margin
0.00%-93.00%-123.65%0.00%-440.53%
Pretax Profit Margin
0.00%-85.36%-121.58%0.00%-331.45%
Net Profit Margin
0.00%14.66%-21.58%0.00%-331.45%
Continuous Operations Profit Margin
0.00%14.66%-21.58%0.00%-331.45%
Net Income Per EBT
100.00%-17.17%17.75%100.00%100.00%
EBT Per EBIT
-102.30%91.78%98.32%99.35%75.24%
Return on Assets (ROA)
-10.88%5.96%-20.20%-134.87%-21.43%
Return on Equity (ROE)
-16.93%6.06%-22.77%-189.06%-21.76%
Return on Capital Employed (ROCE)
-11.74%-38.45%-130.48%-190.30%-28.92%
Return on Invested Capital (ROIC)
-11.74%6.60%-23.16%-190.30%-28.92%
Return on Tangible Assets
-24.95%6.42%-21.29%-140.73%-21.98%
Earnings Yield
-7.90%5.50%-9.31%-40.41%-6.61%
Efficiency Ratios
Receivables Turnover
0.00 40.60 113.95 0.00 19.41
Payables Turnover
3.74 1.08 0.10 0.03 0.35
Inventory Turnover
0.00 0.00 0.00 0.00 61.41K
Fixed Asset Turnover
0.00 342.44 563.41 0.00 34.43
Asset Turnover
0.00 0.41 0.94 0.00 0.06
Working Capital Turnover Ratio
0.00 0.47 1.03 0.00 0.11
Cash Conversion Cycle
-587.06 -330.40 -3.69K -12.18K -1.03K
Days of Sales Outstanding
0.00 8.99 3.20 0.00 18.80
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 <0.01
Days of Payables Outstanding
587.06 339.39 3.69K 12.18K 1.04K
Operating Cycle
0.00 8.99 3.20 0.00 18.81
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 <0.01 -0.02 -0.05 -0.02
Free Cash Flow Per Share
<0.01 <0.01 -0.02 -0.05 -0.02
CapEx Per Share
0.00 <0.01 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 0.96 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
0.00 24.38 0.00 -1.80K -87.07
Capital Expenditure Coverage Ratio
0.00 24.38 0.00 -1.80K -87.07
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.00 0.02 -0.47 0.00 -2.71
Free Cash Flow Yield
-1.77%0.72%-20.08%-26.90%-5.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
19.50 18.18 -10.74 -2.47 -15.12
Price-to-Sales (P/S) Ratio
0.00 2.67 2.32 0.00 50.13
Price-to-Book (P/B) Ratio
4.64 1.10 2.45 4.68 3.29
Price-to-Free Cash Flow (P/FCF) Ratio
46.00 138.92 -4.98 -3.72 -18.26
Price-to-Operating Cash Flow Ratio
20.00 133.22 -4.98 -3.72 -18.47
Price-to-Earnings Growth (PEG) Ratio
0.07 -0.14 0.12 -0.01 0.38
Price-to-Fair Value
4.64 1.10 2.45 4.68 3.29
Enterprise Value Multiple
41.00 -0.52 -1.10 -1.79 -10.88
Enterprise Value
45.95M 940.58K 6.57M 18.61M 33.90M
EV to EBITDA
-23.98 -0.52 -1.10 -1.79 -10.88
EV to Sales
0.00 0.43 1.33 0.00 35.36
EV to Free Cash Flow
-48.81 22.17 -2.85 -2.68 -12.88
EV to Operating Cash Flow
-48.81 21.26 -2.85 -2.68 -13.03
Tangible Book Value Per Share
0.03 0.03 0.03 0.04 0.10
Shareholders’ Equity Per Share
0.03 0.04 0.03 0.04 0.10
Tax and Other Ratios
Effective Tax Rate
0.00 1.17 0.82 <0.01 >-0.01
Revenue Per Share
0.00 0.02 0.03 0.00 <0.01
Net Income Per Share
<0.01 <0.01 >-0.01 -0.07 -0.02
Tax Burden
1.00 -0.17 0.18 1.00 1.00
Interest Burden
0.92 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.22 0.81 0.00 2.31
SG&A to Revenue
0.00 0.30 0.19 0.00 0.70
Stock-Based Compensation to Revenue
0.00 0.00 0.05 0.00 0.65
Income Quality
0.51 0.00 2.16 0.67 0.82
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis